CONMED
CNMD
277 hedge funds and large institutions have $1.82B invested in CONMED in 2025 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 96 increasing their positions, 96 reducing their positions, and 45 closing their positions.
134% more call options, than puts
Call options by funds: $3.91M | Put options by funds: $1.67M
0% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 45
0% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 96
1% less funds holding
Funds holding: 280 → 277 (-3)
2.04% less ownership
Funds ownership: 115.09% → 113.05% (-2%)
15% less capital invested
Capital invested by funds: $2.15B → $1.82B (-$327M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$31.1M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.1M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.11M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$6.32M |
| 5 |
DM
Deerfield Management
New York
|
+$4.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$27.5M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
-$24.6M |
| 3 |
OCM
Osterweis Capital Management
San Francisco,
California
|
-$13.8M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$11.3M |
| 5 |
SAM
Silvercrest Asset Management
New York
|
-$10.1M |
CNMD Hedge Fund Activity: Q2 2025 in Review
277 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2025, worth a combined $1.82B — down 15% from $2.15B a quarter earlier.
Fund positioning in CNMD was balanced in Q2 2025: 45 funds opened new positions, 45 closed out, 96 added to existing stakes and 96 trimmed.
The largest buyer was Fuller & Thaler Asset Management, adding an estimated $31.1M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $27.5M sold.
- 277 institutional investors held CONMED (CNMD) as of Q2 2025, down from 280 in Q1 2025.
- Funds reported $1.82B of CONMED stock for Q2 2025, down 15% quarter-over-quarter.
- 45 funds opened new CONMED positions in Q2 2025 and 45 closed out, a net change of 0 holders.
- The largest CONMED buyer in Q2 2025 was Fuller & Thaler Asset Management, an estimated $31.1M added.
- The largest CONMED seller in Q2 2025 was ArrowMark Colorado Holdings, an estimated $27.5M sold.
Based on aggregated 13F filings for Q2 2025.